New drugs for the treatment of tuberculosis pulmonary: integrative literature review
International Journal of Development Research
New drugs for the treatment of tuberculosis pulmonary: integrative literature review
Received 10th November, 2022; Received in revised form 17th November, 2022; Accepted 22nd December, 2022; Published online 24th January, 2023
Copyright©2023, Gabriel Chaves Chaves et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Objective: The main this article is to bring the main studies about the new treatments for pulmonary tuberculosis, in 2018 to 2022. Methods: An integrative literature review was carried out, synthesizing the results and studies in progress about new drugs anti-tuberculostatic in the treatment of sensitive e resistant pulmonary tuberculosis. Results: The 24 articles and 14 studies were selected and referred exclusively treatments for pulmonary tuberculosis. The results reflect that it is not possible to reduce the treatment to period shorter, more effective regimens an widely distributed to vulnerable people. Final Considerations: In Brazil, the unified health system (SUS) can garantees completely the treatment of sensitive and resistant tuberculosis. The regimen used in Brazil is recommended by the WHO, is the most effective and in association of antibiotics, as recommended by recent studies.
